Privia Health Group financials
$19.62−1.26%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY25 Dec 31 | FY24 Dec 31 | FY23 Dec 31 | FY22 Dec 31 | FY21 Dec 31 |
|---|---|---|---|---|---|
| Revenue | $2.12B | $1.74B | $1.66B | $1.36B | $966.2M |
| Gross profit | $1.87B | $1.51B | $1.46B | $1.19B | $791.5M |
| Gross margin | 88.1% | 86.9% | 88.1% | 87.4% | 81.9% |
| Operating income | $1.69B | $1.35B | $1.32B | $1.03B | $510.4M |
| Net income | $22.9M | $14.4M | $23.1M | -$8.6M | -$188.2M |
| Net margin | 1.1% | 0.8% | 1.4% | −0.6% | −19.5% |
| Diluted EPS | $0.18 | $0.11 | $0.19 | $-0.08 | $-1.83 |
| EBITDA | $1.70B | $1.36B | $1.33B | $1.04B | $512.9M |
| Operating cash flow | $163.4M | $109.3M | $80.8M | $47.2M | $55.1M |
| Free cash flow | $163.4M | $109.3M | $80.8M | $47.2M | $54.5M |
| Diluted shares | 128.9M | 125.6M | 124.7M | 110.7M | 103.0M |
Balance sheet
| Period end | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|
| Cash & equivalents | $479.7M | $491.1M | $389.5M | $348.0M | $320.6M |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | — |
| Total debt | $0.00 | $0.00 | $0.00 | $0.00 | $32.6M |
| Total assets | $1.37B | $1.14B | $999.9M | $792.8M | $686.4M |
| Total liabilities | $578.4M | $452.3M | $392.5M | $273.8M | $236.2M |
| Shareholders' equity | $790.9M | $683.4M | $607.4M | $519.0M | $450.2M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology